This finding is particularly significant, as the PI3K/Akt/Nrf2 pathway has been implicated in various neuroprotective and anti-inflammatory processes [36], and its activation may offer a potential mechanism for the development of health supplements aimed at managing depression. Here, AKT1 is linked to major depressive disorder.